Diversity of NSP1 in Porcine Reproductive and Respiratory Syndrome Virus Isolates from China

Frans Todd^*
*Correspondence: Frans Todd, Department of Biology, George Mason University, Virginia, USA, Email:

Introduction

NSP1 sequences of PRRSV isolates from China were retrieved from publicly available databases and research publications. Multiple sequence alignment was performed using bioinformatics tools to analyze genetic variations and identify conserved region. Phylogenetic trees were constructed to assess the evolutionary relationships among NSP1 sequences and determine the distribution of genetic clusters. Analysis of NSP1 sequences revealed temporal variations in PRRSV isolates from China over the study period. Multiple genetic clusters and subclusters were identified within the NSP1 sequences, indicating significant genetic diversity. Despite genetic diversity, certain regions of NSP1 were highly conserved across isolates, highlighting functional importance [1-3].

Porcine Reproductive and Respiratory Syndrome (PRRS) is a viral disease characterized by reproductive failure in breeding stock and respiratory distress in pigs of all ages. The causative agent, PRRSV, is an enveloped, positive-sense single-stranded RNA virus belonging to the family Arteriviridae. The virus is divided into two major genotypes: PRRSV-1 (European type) and PRRSV-2 (North American type). China has reported cases of both genotypes, with PRRSV-2 being more prevalent. Nonstructural protein 1 (NSP1) is one of the first viral proteins expressed during PRRSV infection and is crucial for viral replication and subgenomic RNA transcription. NSP1 consists of two domains: NSP1α and NSP1β. The diversity of NSP1 among PRRSV isolates can influence viral virulence, immune evasion, and vaccine efficacy. This study focuses on the genetic diversity of NSP1 in PRRSV isolates from China, providing essential data for understanding virus evolution and improving control strategies.

Description

Phylogenetic analysis showed the emergence of distinct lineages and the potential for viral evolution and adaptation. Genetic diversity in NSP1 may influence viral fitness, virulence, and immune evasion strategies. Understanding NSP1 diversity is crucial for vaccine design to ensure broad coverage against diverse viral variants. Monitoring NSP1 diversity can aid in disease surveillance, outbreak investigations, and risk assessment. Factors driving NSP1 diversity may include host immune pressure, antiviral interventions, and viral recombination [4,5].

A total of 50 PRRSV isolates were sequenced for the NSP1 region. The nucleotide sequence identity ranged from 85% to 99%, indicating considerable genetic diversity. The amino acid sequence identity showed a similar range, highlighting the variability at the protein level. Phylogenetic analysis revealed that the NSP1 sequences clustered into several distinct clades, corresponding to known PRRSV lineages. Notably, some isolates formed unique clusters not previously reported, suggesting the emergence of new variants in China. The observed diversity in NSP1 among PRRSV isolates from China underscores the virus's ongoing evolution and adaptation. High genetic variability in NSP1 may impact the virus's pathogenicity, immune evasion mechanisms, and response to vaccination. The emergence of unique NSP1 variants suggests that PRRSV continues to evolve rapidly, potentially complicating control efforts.

Conclusion

The diversity of NSP1 in PRRSV isolates from China between 1996 and 2022 highlights ongoing evolutionary processes and genetic adaptation within the virus population. This knowledge is essential for understanding PRRSV pathogenesis, designing effective control measures, and developing strategies for vaccine development tailored to regional genetic variants. This study provides valuable insights into the genetic diversity of NSP1 in PRRSV isolates from China. The high variability and occurrence of recombination events in NSP1 highlight the challenges in controlling PRRSV. Continuous monitoring of NSP1 and other viral proteins is essential for improving disease control measures and vaccine development.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Poller, Wolfgang, Susmita Sahoo, Roger Hajjar and Ulf Landmesser, et al. "Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets—Recent Insights at Molecular and Cellular Level." Cells 12 (2023): 2660.

Google Scholar, Crossref, Indexed at

2. Rao, Shuquan, Yao Yao and Daniel E. Bauer. "Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation." Genome Med 13 (2021): 41.

Google Scholar, Crossref

3. Perenthaler, Elena, Soheil Yousefi, Eva Niggl and Tahsin Stefan Barakat. "Beyond the exome: the non-coding genome and enhancers in neurodevelopmental disorders and malformations of cortical development." Front Cell Neurosci 13 (2019): 352.

Google Scholar, Crossref, Indexed at

4. Ghanam, Amr R., William B. Bryant and Joseph M. Miano. "Of mice and human-specific long noncoding RNAs." Mamm Genome 33 (2022): 281-292.

Google Scholar, Crossref, Indexed at

5. Nadler, Monica JS, Weipang Chang, Ekim Ozkaynak and Yuda Huo, et al. "Hominoid SVA-lncRNA AK057321 targets human-specific SVA retrotransposons in SCN8A and CDK5RAP2 to initiate neuronal maturation Commun Biol 6 (2023): 347.

Google Scholar, Crossref, Indexed at